Cargando…
A change for the antibacterial treatment policy to decrease carbapenem consumption at a hematopoieteic stem cell transplant center
Autores principales: | Metan, G, Kaynar, L, Yozgat, N, Elmali, F, Kurkcuoglu, C Altay, Alp, E, Cetin, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475158/ http://dx.doi.org/10.1186/2047-2994-4-S1-P175 |
Ejemplares similares
-
The effectiveness of hepa filtered rooms plus fluconazol prophylaxis for preventation of invasive fungal diseases in allogenic stem cell transplant patients
por: Kurkcuoglu, C Altay, et al.
Publicado: (2015) -
Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation
por: Alp, Sehnaz, et al.
Publicado: (2017) -
Eltrombopag for Treatment of Thrombocytopenia Following Hematopoietic Stem Cell Transplantation
por: Güven, Zeynep Tuğba, et al.
Publicado: (2022) -
Factors influencing the early mortality in haematological malignancy patients with nosocomial Gram negative bacilli bacteraemia: a retrospective analysis of 154 cases
por: Metan, Gökhan, et al.
Publicado: (2013) -
Incidence, risk factors and etiological agents in surgical site infections in a developing country
por: Alp, E, et al.
Publicado: (2011)